MIPS Cost Category Updates for 2026
The Cost category is the part of MIPS that many clinicians feel least able to control. There is no attestation screen, no registry upload, and no manual measure selection in the usual sense. CMS scores it from Medicare claims, then compares performance against benchmarks and peers.
That makes it easy to ignore until the feedback report arrives. It also makes it risky.
For 2026, the Cost category remains a major part of MIPS performance planning. For 2027, the clearest signal is continued movement toward more specialty-specific, episode-based measurement and stronger ties between Cost and MIPS Value Pathways, known as MVPs.
This article explains what is stable, what is changing, what to watch, and how to prepare without guessing at data you do not yet have.
Why the MIPS Cost category matters
The MIPS Cost category measures the cost of care provided to Medicare beneficiaries. It is designed to capture whether care is efficient, coordinated, and clinically appropriate across certain services and episodes.
Unlike Quality or Promoting Interoperability, Cost is generally calculated from Medicare administrative claims. That means clinicians and groups usually do not submit cost data directly. CMS uses claims, attribution rules, episode definitions, risk adjustment, and benchmarks to produce the score.
The key point is simple: Cost has a real effect on the final MIPS score, even though it is not submitted like other categories.
For traditional MIPS, Cost has commonly carried a 30% weight when it can be scored. If CMS cannot calculate a Cost score because there are too few attributed cases or no applicable measures, that weight is typically redistributed to other performance categories under MIPS reweighting rules.
That makes the category especially important for:
Groups with high Medicare volume
Specialists tied to procedural or condition-based episodes
Primary care practices with broad patient attribution
Multispecialty groups moving toward MVP reporting
Organizations close to the MIPS performance threshold
The best way to think about Cost is not as a separate compliance task. It is a claims-based reflection of care patterns.
What stays the same in 2026
Several core Cost category features are expected to remain central for the 2026 performance year.
Area | What it means for 2026 planning |
Data source | CMS calculates Cost from Medicare claims rather than a separate practice submission. |
Timing | The 2026 performance year generally affects the 2028 MIPS payment year. |
Category weight | Cost is expected to remain a substantial part of the final MIPS score when it can be scored. |
Measure types | CMS continues to use population-based and episode-based cost measures. |
Attribution | Patients or episodes are assigned to clinicians or groups based on claims rules. |
Case minimums | A measure usually needs enough attributed cases to be scored. |
The familiar population-based measures include Total Per Capita Cost and Medicare Spending Per Beneficiary Clinician. CMS also uses episode-based measures that focus on specific procedures, acute events, or chronic conditions.
A clinician or group may not receive a score on every cost measure. CMS applies case minimums and measure-specific rules. If a group does not meet the requirements for a measure, CMS does not score that measure for the group.
This is one reason cost performance can feel unpredictable. Two groups in the same specialty may see different measures based on patient mix, services billed, and attribution.
The main 2026 updates to watch
CMS updates MIPS through annual rulemaking, measure specifications, and Quality Payment Program materials. Since final details can shift from proposed to final rules, every organization should confirm the current measure specifications before acting on them.
With that said, the direction for 2026 is clear enough to guide planning.
Cost remains closely tied to episode-based measurement
CMS has been building out episode-based cost measures for several years. That direction is expected to continue in 2026.
Episode-based measures look at the cost of care during a defined window tied to a clinical event, condition, or procedure. This may include related services before, during, and after the central event.
For example, an episode measure may capture:
Index service or trigger event
Related evaluation and management visits
Ancillary services
Imaging or testing
Post-acute care
Readmissions or complications when applicable
Other Medicare Part A and Part B claims connected to the episode logic
The business impact is clear. Specialists who once focused mostly on Quality measures may need to study downstream utilization patterns more closely.
MVP alignment is becoming more important
MIPS Value Pathways are intended to make reporting more meaningful by grouping related measures around specialties, conditions, or care models. Cost measures are part of that structure.
For 2026, MVP readiness should include Cost category review, not just Quality measure selection. A group entering an MVP should understand which cost measures may apply, how attribution works, and which care patterns could drive higher episode costs.
This is especially important for multispecialty groups. As MVP participation expands, subgroup reporting and specialty-specific performance views may become more relevant. A multispecialty tax ID may no longer be able to rely on a single broad MIPS strategy for every clinician type.
A practical mips consulting review should connect MVP selection, quality reporting, and cost attribution in one plan rather than treating them as separate workstreams.
Measure specifications deserve more attention
Cost measure specifications are not light reading, but they matter. Small details can change whether a case is attributed, what services are included, and whether an episode is excluded.
For 2026, groups should pay close attention to:
Trigger codes that start an episode
Episode window length
Exclusion rules
Specialty attribution
Risk adjustment factors
Included and excluded service categories
Case minimums
Benchmark methodology
This is not just a technical exercise. If a practice does not understand why CMS attributes certain episodes to it, it cannot respond in a useful way.
Cost performance will depend on coordination beyond the billing clinician
Many Cost measures include services that the attributed clinician does not directly bill. That is by design. CMS wants to measure the cost of the broader episode or beneficiary care pattern.
This can feel unfair, but it reflects the policy goal behind Cost measurement. CMS is looking at whether care is coordinated and whether services remain clinically appropriate across the episode.
For 2026, practices should review patterns such as:
Avoidable emergency department use
Repeat imaging
Unplanned readmissions
Post-acute care variation
High-cost drug or therapy patterns
Referrals to high-cost settings when lower-cost settings may be appropriate
Follow-up gaps after procedures or hospital discharge
The goal is not to reduce needed care. The goal is to identify variation that does not improve outcomes.
How the MIPS Cost category is scored
Cost scoring can be confusing because it happens behind the scenes. A general scoring flow looks like this:
CMS reviews Medicare claims for the performance year.
Cost measures are applied based on measure rules.
Beneficiaries or episodes are attributed to clinicians or groups.
CMS applies exclusions and risk adjustment.
The group’s cost performance is compared with benchmarks.
Measure-level scores are combined into the Cost category score.
The Cost category contributes to the final MIPS score based on its assigned weight.
The most important planning issue is attribution. If a group does not know which beneficiaries or episodes CMS may attribute to it, the Cost score can feel like a surprise.
A sound mips cost strategy starts with prior-year feedback reports. These reports can show which measures applied, where performance was strong, and where costs were above benchmark.
What 2026 means for different practice types
Cost planning is not the same for every specialty.
Primary care practices should watch total cost patterns
Primary care groups are often most exposed to broad population-based cost measures. These measures may reflect the total cost of care for attributed beneficiaries.
Primary care cost review should focus on:
Chronic condition management
Medication adherence workflows
Avoidable emergency department use
Timely follow-up after hospitalization
Specialist referral patterns
Preventive care gaps
Care management documentation
The question is not whether primary care controls every dollar. It does not. The question is whether the practice can reduce preventable variation through better access, follow-up, and coordination.
Procedural specialists should study episode windows
Procedural specialties may see cost variation tied to surgical or procedural episodes.
Useful review areas include:
Site of service
Pre-procedure testing
Device or supply variation when captured in claims
Complication rates
Readmissions
Follow-up care
Post-acute services
Repeat procedures
The biggest opportunities often appear after the index service. A clean procedure with poor follow-up can still produce a costly episode.
Medical specialists should focus on condition-based patterns
Specialists managing chronic or complex conditions may see cost tied to disease progression, medication use, testing frequency, and acute exacerbations.
Areas to review include:
High-cost medication pathways
Lab and imaging frequency
Escalation criteria
Emergency department patterns
Coordination with primary care
Patient education around warning signs
Follow-up timing after acute events
For these groups, documentation and care pathways matter. They help explain severity and support more consistent care.
Projections for 2027
No projection should be treated as a final CMS rule. Still, several trends are likely to shape the 2027 performance year.
Cost will likely stay central to MIPS
There is no strong signal that CMS plans to make Cost a minor category. The agency has long connected MIPS to value-based care, and cost measurement is a core part of that approach.
The exact category weight can change through rulemaking, but groups should plan as if Cost remains material to the final score.
For 2027, the safe planning assumption is this: Cost will continue to matter, and the score will still come from claims data that practices cannot edit after the fact.
More measures may become specialty specific
CMS has continued to develop more clinically focused cost measures over time. In 2027, more specialty-specific or episode-specific measures may be proposed, refined, or adopted.
That could help make scoring more relevant. It could also create new exposure for practices that have not previously received many Cost scores.
Specialties that should watch rulemaking closely include those with high-cost procedures, complex chronic disease management, frequent imaging, post-acute care use, or high Part B drug spending.
MVPs may put more pressure on Cost readiness
As MVPs mature, Cost will likely become harder to ignore. Groups that choose an MVP may need to understand how Cost fits into the pathway.
By 2027, more organizations may compare clinicians and subgroups through a specialty-specific lens. That can make internal variation more visible.
A group with strong overall performance may still find that one specialty line has high episode costs. The earlier that variation is found, the easier it is to address.
Benchmarks may feel tighter
Cost benchmarks are based on performance data and CMS methodology. When more groups improve, benchmarks can become harder to beat.
This does not mean every score will fall. It means practices should not expect a static target.
For 2027 planning, compare performance year over year. Look for direction, not just one score. A group that improves its own cost pattern may still need to understand how it compares with peers.
A practical preparation plan for 2026 and 2027
The right Cost strategy is specific, claims-aware, and tied to clinical operations. It does not rely on generic advice to “spend less.”
Review prior feedback reports
Start with the most recent MIPS feedback report and any available cost measure details. Identify which measures were scored and which were not.
Look for:
Measures with low scores
Measures with high beneficiary or episode counts
Large year-to-year changes
Measures close to benchmark cut points
Differences between group and individual performance where available
Map cost measures to service lines
Next, connect the scored measures to real clinical areas. A cost measure should not sit only in a compliance file.
For each measure, ask:
Which clinicians or locations drive the attributed cases?
Which services are included in the cost window?
Which external facilities or referral partners appear often?
Which costs are clinically expected?
Which costs suggest avoidable variation?
Separate coding issues from care pattern issues
Higher cost can stem from sicker patients, coding variation, site-of-service patterns, complications, or fragmented care. Do not assume one cause.
Risk adjustment helps, but it does not replace accurate coding and documentation. If diagnoses are incomplete or inconsistent, patient complexity may not be fully reflected in claims data.
Build a short list of changes
A useful Cost plan should be narrow enough to execute.
Examples include:
Improve post-discharge contact for high-risk patients
Review imaging repeat rates for selected episodes
Standardize pre-procedure testing criteria
Create preferred post-acute communication steps
Review referral patterns for high-variation services
Track unplanned readmissions after specific procedures
The best changes serve patients first. Cost improvement follows when unnecessary friction and variation come out of the care path.
What to monitor in CMS rulemaking
For 2026 updates and 2027 projections, the most important sources are CMS rulemaking, the Quality Payment Program website, measure specification documents, and official feedback reports.
Watch for changes in:
Cost category weight
New or removed cost measures
Episode definitions
Attribution rules
Case minimums
Risk adjustment methodology
MVP cost measure alignment
Reweighting policies
Subgroup reporting requirements
Performance threshold and scoring policies
Because MIPS runs on a two-year payment lag, the planning window is easy to miss. The 2026 performance year affects future payment adjustments, and 2027 planning should begin before the 2026 feedback cycle is complete.
The takeaway for 2026 and 2027
The Cost category is no longer something to review after scores arrive. For 2026, practices should treat Cost as a live performance category driven by claims, episodes, attribution, and care patterns. For 2027, the safest projection is more specialty-specific measurement, closer MVP alignment, and continued pressure to explain variation with data.
Start with the reports you already have. Identify the measures that affect your score. Learn the attribution rules. Then focus on a short list of care changes that reduce avoidable cost while protecting clinical quality.
That is the practical path through the MIPS Cost category: understand what CMS measures, find where variation comes from, and act early enough for the claims data to reflect better care.
Comments